AstraZeneca resumes U.S. Covid-19 vaccine trial and Johnson & Johnson prepares to do same.
AstraZeneca's U.S. trial was paused on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial.
U.S. Health and Human Services Deputy Chief of Staff Paul Mango also told reporters he was optimistic a U.S. trial by J&J would resume. J&J paused its large, late-stage trial last week after a study participant became ill and the company said an independent safety panel was investigating. AstraZeneca trials in the United Kingdom, Brazil and South Africa resumed last month even as the U.S. Food and Drug Administration continued its investigation into the case.
Reuters earlier this week reported that the FDA had completed its review and that the AstraZeneca U.S. trial was set to resume as early as this week, citing four sources familiar with the situation.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. - WSJFederal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Read more »
AstraZeneca resumes U.S. COVID-19 vaccine trial, optimism seen for J&JAstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by U.S. regulators, the company said on Friday.
Read more »
WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter.
Read more »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Read more »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Read more »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Read more »